miR-203 inhibits cellular progression (proliferation, metastasis, tumor angiogenesis) and modulates the tumor microenvironment through targeting multiple oncogenic proteins, such as the p53 pathway; it also exhibits potential as a therapeutic target [29, 33, 34]. Here, TP53 is linked to neoplasm.